Related Experiment Video
Updated: Aug 13, 2026

Utilizing the Antigen Capsid-Incorporation Strategy for the Development of Adenovirus Serotype 5-Vectored Vaccine Approaches
Published on: May 6, 2015
[Antigen strategy: a new way for gene therapy]
Abstract:
Synthetic purine-rich or pyridine-rich oligonucleotides have been shown to form stable triplex by binding to specific homopurine-homopyridine sequences in double-stranded DNA. Several studies have suggested that triplex formation in the transcription-regulated regions of genes could inhibit their transcription in vitro or in vivo. This new technology was called antigene strategy, which would be of great value in the treatment of cancer and virus infection. However, the low stability of triplex and restricting target selection of homopurine-homopyridine tracts in selected genes greatly reduced its utility in antigen strategies. Further work is still needed.
More Related Videos
09:20Isolation of Next-Generation Gene Therapy Vectors through Engineering, Barcoding, and Screening of Adeno-Associated Virus (AAV) Capsid Variants
Published on: October 18, 2022
10:00Development of Mesenchymal Stem Cell Membrane-Enveloped Nanovesicles for Enhanced Gene Delivery
Published on: February 17, 2026
Related Concept Videos
In-vitro Mutagenesis
Gene Therapy
Gene Therapy
Tumor Immunotherapy
Pharmacogenomics: Identification of New Drug Targets
Microorganisms in Medicine and Therapeutics